Emergen Research Logo The increasing prevalence of liver diseases worldwide is a major growth driver in the liver disease therapeutics mark ...
Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED), a leading API and formulation manufacturer, announces that the Subject Expert Committee (SEC) of CDSCO has approved its Investigational New Drug ...
Discover how circulating cell-free DNA (cfDNA) is transforming the diagnosis and monitoring of metabolic diseases like ...
Glaucoma is a serious eye disease that gradually damages the optic nerve, leading to vision loss and, if left untreated, blindness.
Newspoint on MSN1d
Increasing liver fat can be fatal, know from the doctor how to prevent Fatty Liver and NAFLDDue to today's hectic life and unhealthy lifestyle, Fatty Liver is becoming a common problem. Especially Non-Alcoholic Fatty ...
The liver is a vital organ responsible for detoxifying toxins. Certain foods can 'clean out your liver' and reduce your risk ...
Metabolic dysfunction-associated fatty liver disease (MAFLD) has become a growing global health concern, affecting millions ...
Liver fibrosis is a major global health concern, developing as a result of chronic liver diseases (CLDs) such as viral ...
SLIM LIVER was the first clinical trial to test semaglutide as a treatment for MASLD in people living with HIV. MASLD, previously known as non-alcoholic fatty liver disease (NAFLD), is a common and ...
Metabolic dysfunction-associated fatty liver disease (MAFLD) has become a growing global health concern, affecting millions ...
The liver is essential for digestion, metabolism, detoxification, and fluid regulation. While alcohol abuse is a known cause ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback